Sarepta Therapeutics buy BiotechBee
Start price
29.10.23
/
50%
€15.16
Target price
31.03.26
€150.00
Performance (%)
-
End price
30.10.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sarepta Therapeutics | 11.471% | 11.471% | -6.880% |
| iShares Core DAX® | 0,56 % | 0,44 % | 5,87 % |
| iShares Nasdaq 100 | -0,16 % | 1,62 % | 37,06 % |
| iShares Nikkei 225® | 1,10 % | 9,61 % | 65,64 % |
| iShares S&P 500 | 0,01 % | 0,69 % | 25,68 % |
According to BiotechBee what are the pros and cons of Sarepta Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year